# Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain

> **NCT00521183** · PHASE1 · COMPLETED · sponsor: **Brian Lally** · enrollment: 2 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** Cytochlor
- **DRUG:** Tetrahydrouridine
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT00521183
- **Lead sponsor:** Brian Lally
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2014-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00521183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00521183, "Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00521183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*